4D Printing in Healthcare Global Market Report 2024

The 4D printing in healthcare market size has grown strongly in recent years. It will grow from $8.0 billion in 2023 to $8.65 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The expansion observed during the historical period can be credited to the increasing demand for patient-specific solutions, advancements in bioprinting and tissue engineering, ongoing innovations in 3D printing technology, and the development of new materials.

The 4D printing in healthcare market size is expected to see strong growth in the next few years. It will grow to $11.59 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The projected growth in the forecast period is driven by advancements in personalized medicine, material science, breakthroughs in tissue engineering, and the increasing demands of an aging population for healthcare services. Key trends anticipated in this period include the rise of customized implants and prosthetics, the development of responsive drug delivery systems, the emergence of biocompatible and bioresorbable constructs, the integration of smart wearables for monitoring and treatment purposes, as well as advancements in tissue engineering and regenerative medicine.

The burgeoning number of surgical procedures is poised to drive the expansion of 4D printing within the healthcare market in the foreseeable future. With its capacity to craft personalized medical implants and devices tailored precisely to individual patient anatomy, 4D printing meets the escalating demand for customized healthcare solutions aimed at optimizing surgical outcomes and patient recovery. By facilitating the fabrication of intricate structures capable of adapting to specific patient requirements, 4D printing enhances treatment efficacy and augments patient satisfaction. This trend is exemplified by data from the American Society for Metabolic and Bariatric Surgery (ASMBS) in June 2022, which reported a notable increase in bariatric surgeries performed in 2021 compared to the previous year, reaching approximately 262,893 procedures. Additionally, insights from Austin Publishing Group in May 2023 underscore the global healthcare system's significant volume of more than 300 million major surgical procedures annually. Consequently, the upsurge in surgical interventions serves as a catalyst for the growth of 4D printing applications in the healthcare sector.

Prominent players within the realm of 4D printing in healthcare are channeling their efforts towards innovative technological advancements, particularly in the realm of 4D designs, to bolster their market profitability. 4D designs, integrating the temporal dimension as the fourth component into three-dimensional (3D) designs, are gaining traction as transformative solutions in medical device manufacturing. For instance, UK-based biotechnology firm 4D Biomaterials introduced 4Degra, a photocurable polycarbonate urethane polymer, catering to diverse medical device applications. Distinguished by its adaptability ranging from soft and flexible to firm and rigid, 4Degra is formulated utilizing 4D Biomaterials' proprietary polycarbonate-urethane chemistry. Leveraging various photocurable additive micro and macro scale processes such as DLP, LCD, SLA, and two-photon lithography, 4Degra resins can be cast, applied as coatings, or utilized in 3D printing applications, demonstrating the versatility and potential impact of 4D printing technologies in advancing healthcare innovation.

In October 2021, 3D Systems, an engineering company headquartered in the United States, finalized the acquisition of Volumetric Biotechnologies for an undisclosed sum. This acquisition forms a pivotal part of 3D Systems' strategic vision to expand its capabilities in human organ production and establish a vertically integrated bioprinting platform capable of generating complete replacement organs. Volumetric Biotechnologies, also based in the United States, specializes in printing technology, particularly in the field of 4D printing within the healthcare sector.

Major companies operating in the 4d printing in healthcare market report are McKesson Corporation, Accenture plc., International Business Machines Corporation, Oracle Corporation, Siemens Healthcare, Cognizant Technology Solutions Corporation, GE Healthcare, Quest Diagnostics, Dassault Systems, Cerner Corporation, Genpact Limited., Infor Inc., Allscripts Healthcare Solutions Inc., eClinicalWorks LLC, Athenahealth Inc., Avaya Inc., Stratasys Ltd, EOS GmbH Electro Optical Systems, 3D Systems Inc, The SSI Groups Inc., Materialise NV, CELLINK, CareCloud Corporation, Envisiontec Inc., Allevi Inc, Poietis SAS, Organovo Holdings Inc.

North America was the largest region in the 4D printing in healthcare market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 4d printing in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 4d printing in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

4D printing within the healthcare sector entails the production of personalized medical devices, implants, and structures utilizing materials capable of self-transformation or shape alteration in response to external triggers post-production. This advancement builds upon the foundation of 3D printing by integrating an additional dimension of functionality, allowing for adaptability in shape, properties, or performance over time.

Key variants of 4D printing applied in healthcare encompass fused deposition modeling (FDM), poly jet, stereolithography, and SLS. FDM, a widely adopted additive manufacturing technology in 3D printing, involves essential components such as equipment, 3D printers, 3D bioprinters, programmable materials, shape-memory materials, hydrogels, living cells, and associated software and services. Its applications span across hospitals, clinics, dental laboratories, and various end-user settings.

The 4D printing in healthcare market research report is one of a series of new reports that provides 4D printing in healthcare market statistics, including 4D printing in healthcare industry global market size, regional shares, competitors with 4D printing in healthcare market share, detailed 4D printing in healthcare market segments, market trends, and opportunities, and any further data you may need to thrive in the 4D printing in healthcare industry. This 4D printing in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The 4D printing in the healthcare market includes revenues earned by entities by providing services such as customizable implants and prosthetics, dynamic wound dressings, and patient-specific tissue engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. 4D printing in the healthcare market consists of sales of drug delivery systems, smart surgical tools, biodegradable stents, responsive orthopedic devices, and adaptive wearable devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.